Biogen
(ETR) IDP
Biogen Financials at a Glance
Market Cap
$23.94B
Revenue (TTM)
$9.71B
Net Income (TTM)
$1.29B
EPS (TTM)
$7.80
P/E Ratio
20.91
Dividend
$0.00
Beta (Volatility)
-0.04 (Low)
Dividend
$0.00
Beta (Volatility)
-0.04 (Low)
Price
$165.50
Volume
67
Open
$165.10
Price
$165.50
Volume
67
Open
$165.10
Previous Close
$165.50
Daily Range
$164.65 - $165.50
52-Week Range
$99.00 - $170.80
Dividend
$0.00
Beta (Volatility)
-0.04 (Low)
Price
$165.50
Volume
67
Open
$165.10
Previous Close
$165.50
Daily Range
$164.65 - $165.50
52-Week Range
$99.00 - $170.80
IDP News
IDP: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Biogen
Industry
Biotechnology
Sector
Health CareEmployees
7,500
CEO
Christopher A. Viehbacher, CPA
Website
www.biogen.comHeadquarters
Cambridge, MA 02142, US
IDP Financials
Key Financial Metrics (TTM)
Gross Margin
70%
Operating Margin
19%
Net Income Margin
13%
Return on Equity
7%
Return on Capital
7%
Return on Assets
4%
Earnings Yield
4.78%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$23.94B
Shares Outstanding
146.76M
Volume
67
Short Interest
0.00%
Avg. Volume
904.902
Financials (TTM)
Gross Profit
$6.35B
Operating Income
$2.41B
EBITDA
$2.60B
Operating Cash Flow
$2.20B
Capital Expenditure
$153.81M
Free Cash Flow
$2.05B
Cash & ST Invst.
$3.82B
Total Debt
$6.95B
Biogen Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$2.18B
-11.2%
Gross Profit
$1.49B
-20.6%
Gross Margin
68.12%
N/A
Market Cap
$23.94B
N/A
Market Cap/Employee
$3.15M
N/A
Employees
7,605
N/A
Net Income
$48.90M
-118.3%
EBITDA
$572.34M
+6.9%
Quarterly Fundamentals
Net Cash
$3.13B
+26.4%
Accounts Receivable
$1.87B
+32.9%
Inventory
$2.17B
-11.9%
Long Term Debt
$6.87B
+40.7%
Short Term Debt
$80.41M
-95.4%
Return on Assets
4.39%
N/A
Return on Invested Capital
7.20%
N/A
Free Cash Flow
$468.03M
-41.5%
Operating Cash Flow
$511.93M
-32.7%